Hair cure firm heads for market

A company working on a hair cloning treatment to tackle baldness said today it was looking to raise £15m (22m) through a stock market flotation.

Proceeds from the proposed listing will enable Cambridge-based Intercytex to fund new tests on its ICX-TRC baldness treatment which is about to enter mid-stage clinical trials on patients and could be on the market by 2010.